加入官方line@ 加入FB粉絲團
  • 免費註冊
  • 加入官方line@
  • 加入FB粉絲團

台股 » 個股 » 健亞 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

健亞

(4130)
可現股當沖
  • 股價
    23.90
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    107張
  • 產業
    上櫃 生技醫療類股

  • 150人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
健亞 (4130)籌碼相關－富邦-七賢 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效，來找出真正獲利的贏家所在券商分點，進而追蹤此贏家所操作的股票與軌跡。

股票投資新手教室：一秒知道是否上對大戶列車

富邦-七賢 券商分點個股進出

富邦-七賢 券商分點全部個股操作績效/獲利分析

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/04/1700.00124.3024.15-1215-0.46%
2024/04/15024.8000.0024.5502160.00%
2024/04/08125.1500.0025.0512110.47%
2024/03/28025.4000.0025.0502240.00%
2024/03/20024.9500.0024.7502300.00%
2024/03/15025.4000.0025.1002330.00%
2024/03/11025.2500.0025.1002370.00%
2024/03/0700.00125.8525.70-1244-0.41%
2024/03/04126.4000.0026.0012510.40%
2024/03/01026.2000.0026.3002560.00%
2024/02/22025.6500.0026.1002710.00%
2024/02/21025.6500.0025.6002590.00%
2024/02/19025.7000.0025.5002590.00%
2024/02/02025.4000.0024.9002560.00%
2024/02/0100.00125.0524.95-1258-0.39%
2024/01/29025.7000.0025.4002680.00%
2024/01/0200.00126.8026.70-1340-0.29%
2023/12/2800.00426.8026.70-4342-1.17%
2023/12/20326.7000.0026.6533310.91%
2023/12/1200.00527.1126.95-5331-1.51%
2023/12/0400.00128.1028.25-1322-0.31%
2023/12/0100.00127.9027.90-1316-0.32%
2023/11/28127.5500.0027.5013150.32%
2023/11/27128.0500.0027.9013210.31%
2023/11/1600.00227.0027.15-2346-0.58%
2023/11/1500.00126.9026.75-1344-0.29%
2023/11/13326.6700.0026.7033440.87%
2023/11/0600.00127.3027.40-1359-0.28%
2023/11/03327.18327.2026.9003570.00%
2023/11/02126.9500.0026.6013500.28%
2023/11/01226.20126.7026.8513460.29%
2023/10/30226.60226.8826.4003390.00%
2023/10/27126.50126.4526.5503320.00%
2023/10/25125.7500.0025.6513230.31%
2023/09/0800.00127.3027.30-1660-0.15%
2023/09/0500.00327.6327.40-3693-0.43%
2023/09/01627.7100.0027.6067070.85%
2023/08/3100.00428.1027.75-4712-0.56%
2023/08/30127.5000.0027.5017140.14%
2023/08/29127.3500.0027.2517490.13%
2023/08/28428.101228.0727.15-8785-1.02%
2023/08/251227.96228.1528.05107761.29%
2023/08/2400.00126.7526.80-1765-0.13%
2023/08/1800.00426.5026.60-4894-0.45%
2023/08/1700.00126.6026.60-1973-0.10%
2023/08/16226.10326.3026.30-11,015-0.10%
2023/08/1000.00127.3027.00-11,076-0.09%
2023/08/04127.9000.0027.9011,1770.08%
2023/08/0200.001127.5527.55-111,196-0.92%
2023/07/27127.90128.1028.1001,2790.00%
2023/07/25128.2000.0028.2011,3990.07%
2023/07/1800.00228.6028.55-21,391-0.14%
2023/07/1700.00329.2029.30-31,412-0.21%
2023/06/2900.00130.5030.75-11,427-0.07%
2023/06/2800.001.129.8930.20-1.11,403-0.08%
2023/06/27129.7000.0029.7011,3970.07%
2023/06/02430.6000.0030.2041,5250.26%
2023/06/0100.00030.8030.8001,4990.00%
2023/05/26130.00129.6529.6501,4880.00%
2023/05/2500.000.130.8530.80-0.11,469-0.01%
2023/05/2400.00531.7031.45-51,446-0.35%
2023/05/23230.88231.3531.3001,4270.00%
2023/05/2200.00730.4930.55-71,368-0.51%
2023/05/19129.85129.7029.7001,3390.00%
2023/05/18128.80129.5529.5501,3070.00%
2023/05/1700.00328.4029.00-31,324-0.23%
2023/05/1600.00127.5028.15-11,363-0.07%
2023/05/15127.6000.0027.3011,4240.07%
2023/05/12227.6800.0027.7521,6110.12%
2023/05/11329.5000.0028.1531,8310.16%
2023/05/10329.55329.9530.3001,8230.00%
2023/05/09229.10329.3729.85-11,801-0.06%
2023/05/08129.50129.1029.1001,8310.00%
2023/05/05130.35130.8029.8501,8310.00%
2023/05/04230.33230.4030.4501,8240.00%
2023/05/03330.18330.2529.9001,8150.00%
2023/04/27226.93526.9727.20-31,712-0.18%
2023/04/2600.00226.9526.90-21,748-0.11%
2023/04/24127.60427.5327.60-31,804-0.17%
2023/04/21127.10127.2026.9001,8210.00%
2023/04/20228.30129.2027.9511,8580.05%
2023/04/19328.80128.6029.1021,8670.11%
2023/04/1800.00228.2028.10-21,928-0.10%
2023/04/1700.00828.2028.10-82,029-0.39%
2023/04/10126.851026.9526.85-92,493-0.36%
新藥研發 浩鼎子公司抗癌新藥申請一期臨床 健亞明年完成試驗Anue鉅亨－2022/09/12
...詳全文
健亞轉投資浩宇超音波D針具追蹤系統 獲美台上市許可UDN聯合新聞網－2022/05/09
健亞（4130）今（9）日宣布，轉投資浩宇生醫公司開發的NAVIRFA（納維爾）超音波3D手術針具追蹤系統，雙雙取得美、......詳全文
健亞轉拓資浩宇NaviFUS®產品 首獲研究用途設備訂單UDN聯合新聞網－2021/03/15
健亞（4130）今（15）日宣布，轉投資的浩宇生醫，下半年將取得肝癌治療產品NAVIRFA®之美國510（k）及台灣二類......詳全文
健亞 相關文章